Cargando…

Costing analysis of a digital first-line treatment platform for patients with knee and hip osteoarthritis in Sweden

Osteoarthritis (OA) constitutes a major and increasing burden on patients, health care systems and the broader society. It is estimated that around a quarter of the adult population is affected by OA in the knee and hip and that the prevalence of OA will increase over the coming decades largely due...

Descripción completa

Detalles Bibliográficos
Autores principales: Ekman, B., Nero, H., Lohmander, L. S., Dahlberg, L. E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423097/
https://www.ncbi.nlm.nih.gov/pubmed/32785226
http://dx.doi.org/10.1371/journal.pone.0236342
_version_ 1783570114764865536
author Ekman, B.
Nero, H.
Lohmander, L. S.
Dahlberg, L. E.
author_facet Ekman, B.
Nero, H.
Lohmander, L. S.
Dahlberg, L. E.
author_sort Ekman, B.
collection PubMed
description Osteoarthritis (OA) constitutes a major and increasing burden on patients, health care systems and the broader society. It is estimated that around a quarter of the adult population is affected by OA in the knee and hip and that the prevalence of OA will increase over the coming decades largely due to aging and adverse life-style factors. Prevention and effective care are critical to manage the challenges posed by OA. Digital technologies offer opportunities to deliver cost-effective care for chronic diseases, including for OA. We report the results of a costing analysis of a new digital platform for delivering first-line care including disease information and physiotherapy to patients with OA and compare this with an existing face-to-face model of treatment. Both models are in accordance with National Treatment Guidelines in Sweden. The results show that overall the digital model costs around 25% of the existing face-to-face model of care. Based on existing evidence on the effects of these models, our findings also suggest that the digital platform offers a cost-effective alternative to the existing model of OA care. Depending on the extent to which the digital model substitutes for the existing model of care, significant resources can be saved.
format Online
Article
Text
id pubmed-7423097
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-74230972020-08-20 Costing analysis of a digital first-line treatment platform for patients with knee and hip osteoarthritis in Sweden Ekman, B. Nero, H. Lohmander, L. S. Dahlberg, L. E. PLoS One Research Article Osteoarthritis (OA) constitutes a major and increasing burden on patients, health care systems and the broader society. It is estimated that around a quarter of the adult population is affected by OA in the knee and hip and that the prevalence of OA will increase over the coming decades largely due to aging and adverse life-style factors. Prevention and effective care are critical to manage the challenges posed by OA. Digital technologies offer opportunities to deliver cost-effective care for chronic diseases, including for OA. We report the results of a costing analysis of a new digital platform for delivering first-line care including disease information and physiotherapy to patients with OA and compare this with an existing face-to-face model of treatment. Both models are in accordance with National Treatment Guidelines in Sweden. The results show that overall the digital model costs around 25% of the existing face-to-face model of care. Based on existing evidence on the effects of these models, our findings also suggest that the digital platform offers a cost-effective alternative to the existing model of OA care. Depending on the extent to which the digital model substitutes for the existing model of care, significant resources can be saved. Public Library of Science 2020-08-12 /pmc/articles/PMC7423097/ /pubmed/32785226 http://dx.doi.org/10.1371/journal.pone.0236342 Text en © 2020 Ekman et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Ekman, B.
Nero, H.
Lohmander, L. S.
Dahlberg, L. E.
Costing analysis of a digital first-line treatment platform for patients with knee and hip osteoarthritis in Sweden
title Costing analysis of a digital first-line treatment platform for patients with knee and hip osteoarthritis in Sweden
title_full Costing analysis of a digital first-line treatment platform for patients with knee and hip osteoarthritis in Sweden
title_fullStr Costing analysis of a digital first-line treatment platform for patients with knee and hip osteoarthritis in Sweden
title_full_unstemmed Costing analysis of a digital first-line treatment platform for patients with knee and hip osteoarthritis in Sweden
title_short Costing analysis of a digital first-line treatment platform for patients with knee and hip osteoarthritis in Sweden
title_sort costing analysis of a digital first-line treatment platform for patients with knee and hip osteoarthritis in sweden
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423097/
https://www.ncbi.nlm.nih.gov/pubmed/32785226
http://dx.doi.org/10.1371/journal.pone.0236342
work_keys_str_mv AT ekmanb costinganalysisofadigitalfirstlinetreatmentplatformforpatientswithkneeandhiposteoarthritisinsweden
AT neroh costinganalysisofadigitalfirstlinetreatmentplatformforpatientswithkneeandhiposteoarthritisinsweden
AT lohmanderls costinganalysisofadigitalfirstlinetreatmentplatformforpatientswithkneeandhiposteoarthritisinsweden
AT dahlbergle costinganalysisofadigitalfirstlinetreatmentplatformforpatientswithkneeandhiposteoarthritisinsweden